Insulet
PODD
$361.90
Share price
-2.65%
Change (1 day)
49.79%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.
Earnings for Insulet (PODD)
Earnings in 2024 (TTM): C$0.47 Billion
According to Insulet's latest financial reports the company's current earnings are C$2.07 Billion. , an increase over its 2023 earnings that were of C$0.35 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Insulet from 2006 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | C$0.48 B | 36.72% |
| 2023 | C$0.35 B | 481.9% |
| 2022 | C$60.52 M | -45.24% |
| 2021 | C$0.11 B | 43.35% |
| 2020 | C$77.09 M | 18.51% |
| 2019 | C$65.05 M | 41.16% |
| 2018 | C$46.08 M | -711.95% |
| 2017 | -C$7.54 Million | -56.85% |
| 2016 | -C$17.46 Million | -79.31% |
| 2015 | -C$84.39 Million | 63.85% |
| 2014 | -C$51.5 Million | 31.04% |
| 2013 | -C$39.31 Million | -21.96% |
| 2012 | -C$50.37 Million | |
| 2010 | -C$48.04 Million | -42.38% |
| 2009 | -C$83.37 Million | -33.56% |
| 2008 | -C$0.13 Billion | 65.93% |
| 2007 | -C$75.62 Million | 209.75% |
| 2006 | -C$24.42 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | C$56.91 M | -88.18% | 🇺🇸 USA |
 | -C$0.14 Billion | -127.25% | 🇺🇸 USA |
 | C$1.02 B | 112.31% | 🇺🇸 USA |
 | C$24.49 B | 4,986.61% | 🇺🇸 USA |
 | C$9.84 B | 1,945.20% | 🇺🇸 USA |
 | C$8.39 B | 1,643.66% | 🇮🇪 Ireland |
 | C$17.80 B | 3,597.99% | 🇺🇸 USA |